Based in Germantown, MD, Intrexon (XON) scheduled an $ 124 million IPO with a market capitalization of $ 1.4 billion at a price range mid-point of $ 15, for Thursday, August 8, 2013.
Nine other IPOs were scheduled for the week of August 5. The full IPO calendar can be found at IPOpremium.
- S-1 filed July 29, 2013
- Manager, Joint Managers: J.P. Morgan; Barclays
- Co-Managers: Griffin Securities; Mizuho Securities
XON believes it is a leader in the field of synthetic biology, an emerging and rapidly evolving discipline that applies engineering principles to biological systems.
Q1 ’13 $ 4 million in revenue with a $ 36 million loss.
One person owns 71%, apparently no venture capitalists, and no collaborators are investors. No patents, yet.
XON is bringing its technology to the market through collaborations, of which there are currently nine. Two are private companies and seven are public. The only large collaborator is
Complete Story »